Related Experiment Video
Updated: Jun 7, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Role of Lipoprotein(a) Reduction in Cardiovascular Disease
Uma Schuth1, Kieran Gill2, Pyotr Telyuk3
1Faculty of Medicine, St Andrews University, St Andrews KY16 9ST, UK.
Insights
Lipoprotein(a) (Lp(a)) is a key genetic risk factor for cardiovascular diseases. While treatments are limited, emerging research offers promising strategies for Lp(a) reduction and cardiovascular disease prevention.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Biochemistry
Background:
- Lipoprotein(a) (Lp(a)) is identified as a significant risk factor for various cardiovascular diseases.
- Lp(a) levels are genetically determined and independently correlate with cardiovascular disease risk, irrespective of lifestyle factors.
Purpose of the Study:
- To review the biochemistry and mechanism of action of Lp(a).
- To examine the association between Lp(a) and cardiovascular diseases.
- To explore potential therapeutic strategies for Lp(a) reduction.
Main Methods:
- Literature review of recent studies on Lp(a).
- Analysis of biochemical and genetic data related to Lp(a).
- Evaluation of current and emerging treatment options.
Main Results:
- Lp(a) plays a crucial role in cardiovascular pathology.
- Genetic factors significantly influence Lp(a) levels and associated risk.
- Limited but promising therapeutic avenues for Lp(a) reduction exist.
Conclusions:
- Understanding Lp(a) is vital for cardiovascular disease risk assessment.
- Targeting Lp(a) presents a potential strategy for cardiovascular disease prevention.
- Further research into Lp(a) therapies is warranted.
Abstract:
Recent studies have shown that lipoprotein(a) (Lp(a)) is an important risk factor for a plethora of different cardiovascular diseases. It has been proven that Lp(a) levels are genetically determined and correlate with risk of cardiovascular disease, independent of lifestyle factors. As of yet, treatment options to reduce Lp(a) levels are limited, but new research into Lp(a) reduction yields promising results. This review delves into Lp(a)'s biochemistry and mechanism of effect, the association between Lp(a) and cardiovascular diseases, and possible therapies to minimise cardiovascular disease.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

